Both in Pharmaceuticals
Design Therapeutics vs Obsidian Therapeutics
Over the past year DSGN returned −27.3% and OBX returned −38.3%; their daily moves had a correlation of 0.26.
DSGN −27.3% OBX −38.3%Growth of $1, one year, split-adjusted
| Metric | DSGN | OBX |
|---|---|---|
| Price | $10.63 | $10.99 |
| Market cap | $665.2M | $678.9M |
| Today | +2.80% | −16.93% |
| 1 month | −11.2% | −16.9% |
| 6 months | −26.9% | — |
| Year to date | +13.3% | — |
| 1 year | +62.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $207.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 55.4% | — |
| Short % of float | 21.8% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).